Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 12;13:1015338. doi: 10.3389/fphar.2022.1015338

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zhou, Zhan and Wei.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The distribution of IOP-lowering efficacy of PGAs at different time points of therapy and the distribution of ocular side events of PGAs in previous RCTs. (A) The distribution of the IOP-lowering efficacy of PGAs at 1M, 3M, and 6M. The abscissa represents the mean IOP reduction from baseline to the endpoint. The ordinate represents the data from different reported literatures. (A1): The distribution of IOP-lowering efficacy of PGAs at 1 month. (A2): The distribution of IOP-lowering efficacy of PGAs at 3 months. (A3): The distribution of IOP-lowering efficacy of PGAs at 6 months. Red circle: Latanoprost; Green square: Bimatoprost; Dark triangle: Travoprost. (B) The distribution of ocular side events of PGAs in previous RCTs. The horizontal axis represents the incidence of ocular side effects. The pale green columns in the top represent the ocular side effects in Bimatoprost. The faint yellow columns in the middle represent the ocular side effects in Travoprost. The pale blue columns in the bottom represent the ocular side effects in Latanoprost. Green square: conjunctival hyperemia; yellow circle: growth of eyelashes; blue circle: other discomfort.